Deutsche Bank
OXFD

Deutsche Bank’s Oxford Immunotec Global PLC Ordinary Shares OXFD Stock Holding History

Deutsche Bank’s Portfolio OXFD Stock Details OXFD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-100
Closed -$1K – 4601
2020
Q3 		$1K Buy
+100
New +$1.33K ﹤0.01% 4313
2020
Q2 		– Sell
-11,236
Closed -$104K – 4576
2020
Q1 		$104K Buy
11,236
+7,071
+170% +$98.8K ﹤0.01% 3231
2019
Q4 		$69K Buy
+4,165
New +$67.5K ﹤0.01% 3784
2019
Q3 		– Sell
-337,812
Closed -$4.65M – 5451
2019
Q2 		$4.65M Buy
337,812
+169,031
+100% +$2.59M ﹤0.01% 1864
2019
Q1 		$2.9M Buy
168,781
+74,232
+79% +$1.17M ﹤0.01% 2225
2018
Q4 		$1.21M Sell
94,549
-15,318
-14% -$232K ﹤0.01% 2749
2018
Q3 		$1.78M Buy
109,867
+37,829
+53% +$541K ﹤0.01% 2937
2018
Q2 		$929K Buy
72,038
+38,195
+113% +$516K ﹤0.01% 3481
2018
Q1 		$420K Sell
33,843
-23,035
-40% -$280K ﹤0.01% 3806
2017
Q4 		$793K Buy
56,878
+27,384
+93% +$401K ﹤0.01% 3355
2017
Q3 		$493K Sell
29,494
-19,280
-40% -$314K ﹤0.01% 3438
2017
Q2 		$818K Sell
48,774
-24,000
-33% -$359K ﹤0.01% 3162
2017
Q1 		$1.13M Buy
72,774
+52,140
+253% +$745K ﹤0.01% 2579
2016
Q4 		$307K Sell
20,634
-8,538
-29% -$120K ﹤0.01% 3454
2016
Q3 		$365K Buy
29,172
+1,355
+5% +$13.6K ﹤0.01% 3353
2016
Q2 		$249K Buy
27,817
+24,735
+803% +$242K ﹤0.01% 3656
2016
Q1 		$30K Sell
3,082
-1,899
-38% -$19.5K ﹤0.01% 4512
2015
Q4 		$56K Sell
4,981
-576
-10% -$7.13K ﹤0.01% 4346
2015
Q3 		$75K Buy
5,557
+717
+15% +$9.72K ﹤0.01% 4231
2015
Q2 		$67K Buy
4,840
+4,837
+161,233% +$65.4K ﹤0.01% 4449
2015
Q1 		$0 Sell
3
-65,003
-100% -$885K ﹤0.01% 6178
2014
Q4 		$884K Buy
65,006
+5,793
+10% +$79.2K ﹤0.01% 3285
2014
Q3 		$903K Sell
59,213
-12,779
-18% -$196K ﹤0.01% 3107
2014
Q2 		$1.21M Sell
71,992
-20,323
-22% -$366K ﹤0.01% 2808
2014
Q1 		$1.85M Sell
92,315
-21,756
-19% -$471K ﹤0.01% 2447
2013
Q4 		$2.21M Buy
+114,071
New +$2.02M ﹤0.01% 2231

Other funds holding OXFD

FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
ECM
Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return
GPGA
Grandeur Peak Global Advisors Salt Lake City, Utah $427M AUM 39.14% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Deutsche Bank's OXFD Position: Q4 2020 in Review

Deutsche Bank sold out of Oxford Immunotec Global PLC Ordinary Shares (OXFD) in Q4 2020, closing a stake of 100 shares — an estimated $1K sold.

Deutsche Bank first reported a position in OXFD in Q4 2013 and held it in 26 quarters. The position peaked at $4.65M in Q2 2019. 60 funds tracked by Wall St. Rank hold OXFD as of Q4 2020.

  • Deutsche Bank reported no remaining Oxford Immunotec Global PLC Ordinary Shares position as of Q4 2020 after selling out during the quarter.
  • Deutsche Bank sold 100 Oxford Immunotec Global PLC Ordinary Shares shares in Q4 2020, an estimated $1K.
  • Deutsche Bank first reported a position in Oxford Immunotec Global PLC Ordinary Shares in Q4 2013 and held it in 26 quarters.
  • Deutsche Bank's Oxford Immunotec Global PLC Ordinary Shares position peaked at $4.65M in Q2 2019.
  • 60 funds tracked by Wall St. Rank held Oxford Immunotec Global PLC Ordinary Shares as of Q4 2020.

Based on Deutsche Bank's 13F filing for Q4 2020, filed 16 Feb 2021.